On the basis that this explanation of emphysema pathogenesis in AATD reflects the complete picture, correction of deficiency with therapeutic augmentation of AAT should prevent the progression of emphysema. This evidence concerns the gene SERPINA1 and alpha 1-antitrypsin deficiency.